Unknown

Dataset Information

0

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy.


ABSTRACT:

Background

Recent studies have indicated the prognostic value of tumour subtype and pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). However these results were reported after a short follow-up and using a standard Cox model which could be unsatisfactory for time-dependent factors. In the present study, we identified the prognostic factors for long-term outcome after NAC, considering that they could have an inconstant impact over time.

Methods

Prognostic factors from 956 consecutive breast cancer patients treated with NAC were identified and associated with long-term outcomes. We estimated survival by a time function multivariate Cox model regression and stratified by follow-up length.

Results

The prognostic value of tumour histological grade and hormone receptors status varied as distant recurrence-free interval (DRFI) increased. The multivariate analysis identified the following significant prognostic factors: tumour size, N stage, clinical and pathological response to NAC, hormone receptors (HR) status and histological tumour grade. The 'prognostic benefit' of low-grade and positive-HR status decreased over the years. Thus, in the early years after cancer diagnosis, the hazard ratio of distant recurrences in patients with positive-HR status increased from 0.26 (95% CI 0.1-0.4) at 6 months to 2.2 (95% CI 1.3-3.7) at 120 months. The histological tumour grade followed a similar trend. The hazard ratio of grade III patients compared with grade I was 1.83 (95% CI 1.1-2.8) at 36 months and diminished over time to 0.70 (95% CI 0.4-1.3) at 120 months. This indicates that the risk of recurrence for positive-HR patients was 74% lower at 6 months compared with the negative-hormone receptor group, but 30% higher at 5 years and more than double at 10 years. High-grade tumours presented a risk of 83% in the earlier years decreasing to 30% at 10 years versus the low-grade group.

Conclusion

From the present study, we conclude the importance of identifying time-dependent prognostic factors. Distant recurrence-free interval within women who receive NAC are influenced by achieving pCR and breast cancer subtype. Tumours with more aggressive biology have poorer survival during the first 5 years, but if they exceed this point their prognostic impact is no longer significant. Conversely, positive-HR patients remain at risk for distant recurrence for many years.

SUBMITTER: Baulies S 

PROVIDER: S-EPMC4647542 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy.

Baulies S S   Belin L L   Mallon P P   Senechal C C   Pierga J-Y JY   Cottu P P   Sablin M-P MP   Sastre X X   Asselain B B   Rouzier R R   Reyal F F  

British journal of cancer 20150616 1


<h4>Background</h4>Recent studies have indicated the prognostic value of tumour subtype and pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). However these results were reported after a short follow-up and using a standard Cox model which could be unsatisfactory for time-dependent factors. In the present study, we identified the prognostic factors for long-term outcome after NAC, considering that they could have an inconstant impact over time.<h4>Methods</h4>Prognostic f  ...[more]

Similar Datasets

| S-EPMC5862777 | biostudies-literature
| S-EPMC5755619 | biostudies-literature
| S-EPMC10120747 | biostudies-literature
| S-EPMC10156471 | biostudies-literature
| S-EPMC6694396 | biostudies-literature
| S-EPMC8555250 | biostudies-literature
| S-EPMC9455620 | biostudies-literature
| S-EPMC5493088 | biostudies-literature
| S-EPMC9472066 | biostudies-literature
| S-EPMC10175450 | biostudies-literature